Ana Claudia Hilda Cullash Luza

Ana Claudia Hilda Cullash Luza

Auto-generated profile, based on publicly available information

Ana Claudia Hilda Cullash Luza

Faculty of Dentistry, Universidad de San Martín de Porres (USMP), Lima, Peru

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in Odontología Sanmarquina
Verified
Journal Article
Open access
SLSilvia C. Luza-Montero
Silvia C. Luza-Montero
ACAna C. Cullash-Luza
Ana C. Cullash-Luza
Objetivo: Candida albicans es un hongo oportunista responsable de infecciones orales y endodónticas persistentes, cuya prevalencia ha aumentado debido a la resistencia a los tratamientos antifúngicos convencionales. En este contexto, los compuestos naturales con actividad antifúngica representan una alternativa prometedora. Este estudio tuvo como objetivo evaluar la actividad antifúngica del extracto etanólico de Curcuma longa L. (EECl) frente a C. albicans ATCC 10231. Materiales y Métodos: Se utilizó el método de difusión en agar mediante pozos para evaluar la actividad antifúngica. El EECl se probó en concentraciones de 100, 50, 25 y 12.5 mg/mL. Se utilizó nistatina como control positivo. Tras la siembra del hongo en agar YPG y la colocación de los pozos cargados con las soluciones correspondientes, las placas fueron incubadas y se midieron los halos de inhibición en milímetros. Resultados: Todas las concentraciones de EECl mostraron actividad antifúngica, observándose mayores halos a concentraciones más elevadas. Se encontraron diferencias significativas entre los grupos (p = 0.040), aunque el análisis post hoc no reveló diferencias entre las concentraciones de 25, 50 y 100 mg/mL (p = 1.000), lo que indica que incrementar la concentración por encima de 25 mg/mL no mejora sustancialmente la actividad antifúngica. La concentración de 12.5 mg/mL mostró menor actividad que la nistatina (p = 0.026). Conclusión: El EECl demostró actividad antifúngica frente a C. albicans, aunque la nistatina fue más eficaz. Estos hallazgos respaldan el potencial del Curcuma longa L. como agente antifúngico natural, recomendándose más estudios.

16 May 2026 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
ALAna Claudia Hilda Cullash Luza
Ana Claudia Hilda Cullash Luza
MSMaría Elena Salazar-Salvatierra
María Elena Salazar-Salvatierra
SMSilvia Celestina Luza Montero
Silvia Celestina Luza Montero
JYJavier Enrique Castro Yanahida
Javier Enrique Castro Yanahida
ALAllan Clark Gutierrez Leiva
Allan Clark Gutierrez Leiva
JCJorge Raúl Colchado Carhuavilca
Jorge Raúl Colchado Carhuavilca
Enterococcus faecalis is associated with persistent endodontic infections due to its ability to form resistant biofilms. Antimicrobial photodynamic therapy (aPDT) has emerged as a promising alternative approach. This study evaluated the antibiofilm activity of an ethanolic extract of Curcuma longa L. against E. faecalis ATCC 29,212, with and without aPDT. An in vitro biofilm model was used. The minimum biofilm inhibitory concentration (MBIC) was determined. Biofilms were treated with the C. longa extract (7.81-2000 µg/mL) under LED irradiation (aPDT) and without light activation. Chlorhexidine (2%) served as a positive control while untreated biofilms served as negative control. Biofilm biomass was quantified by optical density, and statistical analysis was performed using ANOVA and Tukey's test (p < 0.05). The MBIC was 62.5 µg/mL. aPDT significantly reduced biofilm formation compared to the negative control (p < 0.001). The highest inhibitory effects were observed at 31.25 and 62.5 µg/mL, with effects comparable to those of 2% chlorhexidine under in vitro conditions. The highest concentration (2000 µg/mL) showed reduced activity and a potential paradoxical, concentration-dependent effect. Without light activation, the extract also showed antibiofilm activity, but to a lesser extent. Curcuma longa L. exhibits concentration-dependent antibiofilm activity against E. faecalis, enhanced by aPDT. Reduced efficacy at higher concentrations may be related to aggregation and self-quenching of curcumin. Despite chlorhexidine remaining the clinical reference, C. longa showed comparable effects at optimal concentrations. Limitations include the absence of a light-only control, lack of CFU confirmation, and potential staining risk.